62 related articles for article (PubMed ID: 38655656)
1. Prospective associations of leucocyte subtypes and obesity with the risk of developing cutaneous malignant melanoma in the UK Biobank cohort.
Christakoudi S; Tsilidis KK; Riboli E
BMC Cancer; 2024 May; 24(1):625. PubMed ID: 38783251
[TBL] [Abstract][Full Text] [Related]
2. Is the neutrophil-to-lymphocyte "ratio"nale from head and neck to thyroidology for thyroidologists?: promise or passé?
Sengul I; Sengul D; Kesicioglu T; Cinar E; Detanac D; Pelikán A; Kudlova P
Rev Assoc Med Bras (1992); 2024; 70(5):e20231617. PubMed ID: 38775512
[No Abstract] [Full Text] [Related]
3. Neutrophil-to-Lymphocyte Ratio in Prognosis of Gastric Cancer.
Balta S; Unlu M; Arslan Z; Demırkol S
J Gastric Cancer; 2013 Sep; 13(3):196-7. PubMed ID: 24156042
[No Abstract] [Full Text] [Related]
4. Low lymphocyte count and high monocyte count predicts poor prognosis of gastric cancer.
Feng F; Zheng G; Wang Q; Liu S; Liu Z; Xu G; Wang F; Guo M; Lian X; Zhang H
BMC Gastroenterol; 2018 Oct; 18(1):148. PubMed ID: 30305076
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis.
Portale G; Bartolotta P; Azzolina D; Gregori D; Fiscon V
Langenbecks Arch Surg; 2023 Feb; 408(1):85. PubMed ID: 36781510
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.
Ertekin SS; Mangas C; Riquelme-Mc Loughlin C; Carrera C; Malvehy J; Puig S; Podlipnik S
Acta Derm Venereol; 2024 Apr; 104():adv27571. PubMed ID: 38655656
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
8. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.
Temur I; Kucukgoz Gulec U; Paydas S; Guzel AB; Sucu M; Vardar MA
Eur J Obstet Gynecol Reprod Biol; 2018 Jul; 226():25-29. PubMed ID: 29804024
[TBL] [Abstract][Full Text] [Related]
10. Absolute and relative differential blood count predicts survival of AJCC stage I-II melanoma patients scheduled for sentinel lymph node biopsy.
Wagner NB; Luttermann F; Gassenmaier M; Forschner A; Leiter U; Garbe C; Eigentler TK
Australas J Dermatol; 2020 Aug; 61(3):e310-e318. PubMed ID: 32050042
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Lee SM; Russell A; Hellawell G
Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
[TBL] [Abstract][Full Text] [Related]
12. Early inflammatory biomarkers and melanoma survival.
Fortes C; Mastroeni S; Zappalà AR; Passarelli F; Ricci F; Abeni D; Michelozzi P
Int J Dermatol; 2023 Jun; 62(6):752-758. PubMed ID: 36872079
[TBL] [Abstract][Full Text] [Related]
13. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.
Arnold M; Singh D; Laversanne M; Vignat J; Vaccarella S; Meheus F; Cust AE; de Vries E; Whiteman DC; Bray F
JAMA Dermatol; 2022 May; 158(5):495-503. PubMed ID: 35353115
[TBL] [Abstract][Full Text] [Related]
14. Association Between Neutrophil-Lymphocyte Ratio and All-Cause Mortality and Cause-Specific Mortality in US Adults, 1999-2014.
Chen Y; Wang W; Zeng L; Mi K; Li N; Shi J; Yang S
Int J Gen Med; 2021; 14():10203-10211. PubMed ID: 34992439
[TBL] [Abstract][Full Text] [Related]
15. Mortality in cutaneous malignant melanoma and its association with Neutrophil-to-Lymphocyte ratio.
Pinto-Paz ME; Cotrina-Concha JM; Benites-Zapata VA
Cancer Treat Res Commun; 2021; 29():100464. PubMed ID: 34598061
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
